Trichomegaly in a 3-year-old girl with alopecia areata

Pediatric Dermatology

Volumn 26, Issue 2, 2009, Pages 188-193

  Nazareth, Michael R ^b   Bunimovich, Olga ^b   Rothman, Ilene L ^a  

^a CHILDREN S HOSPITAL OF BUFFALO   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALOPECIA AREATA; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CHILD; CLINICAL FEATURE; CONGENITAL MALFORMATION; EYELASH; FEMALE; HUMAN; LABORATORY TEST; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; TRICHOMEGALY;

ALOPECIA AREATA; CHILD, PRESCHOOL; EYELASHES; FEMALE; HUMANS;

EID: 65649146779     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2009.00902.x     Document Type: Article

References (66)

1. Santmyire-Rosenberger BR, Albert M. Acquired trichomegaly with topiramate. J Am Acad Dermatol 2005 53 : 362 363. (Pubitemid 40979610)
2. Grossman MC, Cohen PR, Grossman ME. Acquired eyelash trichomegaly and alopecia areata in a human immunodeficiency virus-infected patient. Dermatology 1996 193 : 52 53. (Pubitemid 26257096)
3. Johnstone MA. Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost. Am J Ophthalmol 1997 124 : 544 547. (Pubitemid 27425878)
4. Casson RJ, Selva D. Lash ptosis caused by latanoprost. Am J Ophthalmol 2005 139 : 932 933. (Pubitemid 40614793)
5. O'Toole L, Cahill M, O'Brien C. Eyelid hypertrichosis associated with latanoprost is reversible. Eur J Ophthalmol 2001 11 : 377 379. (Pubitemid 34160718)
6. Strober BE, Potash S, Grossman ME. Eyelash hypertrichosis in a patient treated with topical latanoprost. Cutis 2001 67 : 109 110. (Pubitemid 33756241)
7. Eisenberg DL, Toris CB, Camras CB. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv Ophthalmol 2002 47 (Suppl. 1 S105 S115. (Pubitemid 35238026)
8. Johnstone MA, Albert DM. Prostaglandin-induced hair growth. Surv Ophthalmol 2002 47 (Suppl. 1 S185 S202. (Pubitemid 35232233)
9. Hempstead N, Hempstead RW. Unilateral trichomegaly induced by bimatoprost ophthalmic solution. J Drugs Dermatol 2004 3 : 571 572.
10. Tosti A, Pazzaglia M, Voudouris S et al. Hypertrichosis of the eyelashes caused by bimatoprost. J Am Acad Dermatol 2004 51 (Suppl. 5 S149 S150. (Pubitemid 39423890)
11. Herane MI, Urbina F. Acquired trichomegaly of the eyelashes and hypertrichosis induced by bimatoprost. J Eur Acad Dermatol Venereol 2004 18 : 644 645. (Pubitemid 39255773)
12. Woo TL, Francis IC. Intermittent blurred vision and trichomegaly due to latanoprost. Clin Exp Ophthalmol 2001 29 : 272 273. (Pubitemid 32791448)
13. Harrison DA, Mullaney PB. Familial trichomegaly. Arch Ophthalmol 1997 115 : 1602 1603. (Pubitemid 28007152)
14. Weaver DT, Bartley GB. Cyclosporine-induced trichomegaly. Am J Ophthalmol 1990 109 : 239. (Pubitemid 20048434)
15. Dueland S, Sauer T, Lund-Johansen F et al. Epidermal growth factor receptor inhibition induces trichomegaly. Acta Oncol 2003 42 : 345 346. (Pubitemid 36851154)
16. Wendelin DS, Pope DN, Mallory SB. Hypertrichosis. J Am Acad Dermatol 2003 48 : 161 179. (Pubitemid 36236142)
17. Bayer A, Bagkesen H, Sobaci G. Acquired trichomegaly in uveitis. Can J Ophthalmol 2007 42 : 101 106. (Pubitemid 46408902)
18. Ward KM, Barnett C, Fox LP et al. Eyelash trichomegaly associated with systemic tacrolimus. Arch Dermatol 2006 142 : 248. (Pubitemid 43276549)
19. Jayamanne DG, Dayan MR, Porter R. Cyclosporin-induced trichomegaly of accessory lashes as a cause of ocular irritation. Nephrol Dial Transplant 1996 11 : 1159 1161. (Pubitemid 26182520)
20. Towler HM, Whiting PH, Forrester JV. Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye 1990 4 (Pt 3 514 520. (Pubitemid 20274951)
21. Fenton DA. Hypertrichosis. Semin Dermatol 1985 4 : 58 67.
22. Yamamoto S, Kato R. Hair growth-stimulating effects of cyclosporin A and FK506, potent immunosuppressants. J Dermatol Sci 1994 7 (Suppl. S47 S54. (Pubitemid 24244561)
23. Apaydin C, Gur B, Yakupoglu G et al. Ocular and visual side effects of systemic cyclosporine. Ann Ophthalmol 1992 24 : 465 469.
24. Lacouture ME, Boerner SA, Lorusso PM. Non-rash skin toxicities associated with novel targeted therapies. Clin Lung Cancer 2006 8 (Suppl. 1 S36 S42.
25. Robert C, Soria JC, Spatz A et al. Cutaneous side-effects of kinase inhibitors and blocking antibodies. Lancet Oncol 2005 6 : 491 500. (Pubitemid 40903630)
26. Bouche O, Brixi-Benmansour H, Bertin A et al. Trichomegaly of the eyelashes following treatment with cetuximab. Ann Oncol 2005 16 : 1711 1712. (Pubitemid 41510151)
27. Pascual JC, Banuls J, Belinchon I et al. Trichomegaly following treatment with gefitinib (ZD1839). Br J Dermatol 2004 151 : 1111 1112. (Pubitemid 39573912)
28. Montagut C, Grau JJ, Grimalt R et al. Abnormal hair growth in a patient with head and neck cancer treated with the anti-epidermal growth factor receptor monoclonal antibody cetuximab. J Clin Oncol 2005 23 : 5273 5275. (Pubitemid 46224050)
29. Lane K, Goldstein SM. Erlotinib-associated trichomegaly. Ophthal Plast Reconstr Surg 2007 23 : 65 66. (Pubitemid 46146906)
30. Hilton L. Skin 'Walking Wounded' of cancer tx. Dermatology Times 2007. March 1, 2007.
31. Nanney LB, Stoscheck CM, King LE Jr. et al. Immunolocalization of epidermal growth factor receptors in normal developing human skin. J Invest Dermatol 1990 94 : 742 748. (Pubitemid 20184371)
32. Lacouture ME. Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer 2006 6 : 803 812. (Pubitemid 44450468)
33. Fish EN, Ghislain J, Trogadis J et al. Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events. Cancer Res 1993 53 : 5148 5157. (Pubitemid 23333380)
34. Hernandez-Nunez A, Fernandez-Herrera J, Buceta LR et al. Trichomegaly following treatment with interferon alpha-2b. Lancet 2002 359 : 1107. (Pubitemid 34270734)
35. Howaizi M. Pegylated interferon-induced eyelid and eyebrow trichomegaly during chronic hepatitis C. J Gastroenterol Hepatol 2005 20 : 1945 1946. (Pubitemid 43961059)
36. Kadayifcilar S, Boyacioglu S, Kart H et al. Ocular complications with high-dose interferon alpha in chronic active hepatitis. Eye 1999 13 (Pt 2 241 246. (Pubitemid 29210148)
37. Casanova JM, Puig T, Rubio M. Hypertrichosis of the eyelashes in acquired immunodeficiency syndrome. Arch Dermatol 1987 123 : 1599 1601.
38. Kaplan MH, Sadick NS, Talmor M. Acquired trichomegaly of the eyelashes: a cutaneous marker of acquired immunodeficiency syndrome. J Am Acad Dermatol 1991 25 (5 Pt 1 801 804.
39. Baccard M, Morel P. Excessive growth of eyelashes in patients with acquired immunodeficiency syndrome. Cutis 1994 53 : 83 84. (Pubitemid 24127358)
40. Almagro M, del Pozo J, Garcia-Silva J et al. Eyelash length in HIV-infected patients. AIDS 2003 17 : 1695 1696. (Pubitemid 36951691)
41. Graham DA, Sires BS. Acquired trichomegaly associated with acquired immunodeficiency syndrome. Arch Ophthalmol 1997 115 : 557 558. (Pubitemid 27172720)
42. Klutman NE, Hinthorn DR. Excessive growth of eyelashes in a patient with AIDS being treated with zidovudine. N Engl J Med 1991 324 : 1896.
43. Santiago M, Travassos AC, Rocha MC et al. Hypertrichosis in systemic lupus erythematosus (SLE). Clin Rheumatol 2000 19 : 245 246. (Pubitemid 30341265)
44. Can C, Nigogosyan G. Acquired toxic porphyria cutanea tarda due to hexachlorobenzene. Report of 348 cases caused by this fungicide. JAMA 1963 183 : 88 91.
45. Velez A, Kindelan JM, Garcia-Herola A et al. Acquired trichomegaly and hypertrichosis in metastatic adenocarcinoma. Clin Exp Dermatol 1995 20 : 237 239.
46. Ziakas NG, Jogiya A, Michaelides M. A case of familial trichomegaly in association with oculocutaneous albinism type 1. Eye 2004 18 : 863 864. (Pubitemid 39173429)
47. Rubin P. Disorders of the eyelashes and eyebrows. In : Albert DM, Jakobiec FA, eds. Principles and practice of ophthamology. Philadelphia, PA : WB Saunders, 1994 : 1852.
48. Wong VA, Wade NK. POEMS syndrome: an unusual cause of bilateral optic disk swelling. Am J Ophthalmol 1998 126 : 452 454. (Pubitemid 28422075)
49. Levy Y, Segal N, Ben-Amitai D et al. Eyelash length in children and adolescents with allergic diseases. Pediatr Dermatol 2004 21 : 534 537. (Pubitemid 39363169)
50. Sharma RC, Mahajan VK, Sharma NL et al. Trichomegaly of the eyelashes in dermatomyositis. Dermatology 2002 205 : 305. (Pubitemid 36158548)
51. Pucci N, Novembre E, Lombardi E et al. Long eyelashes in a case series of 93 children with vernal keratoconjunctivitis. Pediatrics 2005 115 : e86 e91. (Pubitemid 43046267)
52. Oliver GL, McFarlane DC. Congenital trichomegaly: with associated pigmentary degeneration of the retina, dwarfism, and mental retardation. Arch Ophthalmol 1965 74 : 169 171.
53. Kondoh T, Amamoto N, Hirota T et al. Very long eyelashes, long eyebrows, sparse hair, and mental retardation in two unrelated boys: an atypical form of Oliver-McFarlane syndrome without retinal degeneration, or a new clinical entity? Am J Med Genet A 2003 120 : 437 438. (Pubitemid 37063785)
54. Haimi M, Gershoni-Baruch R. Autosomal recessive Oliver-McFarlane syndrome: retinitis pigmentosa, short stature (GH deficiency), trichomegaly, and hair anomalies or CPD syndrome (chorioretinopathy-pituitary dysfunction). Am J Med Genet A 2005 138 : 268 271. (Pubitemid 41384245)
55. Haritoglou C, Rudolph G, Kalpadakis P et al. Congenital trichomegaly (Oliver-McFarlane syndrome): a case report with 9 years' follow up. Br J Ophthalmol 2003 87 : 119 120. (Pubitemid 36071792)
56. Gorlin RJ, Cohen MM, Levin LS. de Lange syndrome (Brachmann- de Lange syndrome). New York : Oxford University Press, 1990.
57. Goldstein JH, Hutt AE. Trichomegaly, cataract, and hereditary spherocytosis in two siblings. Am J Ophthalmol 1972 73 : 333 335.
58. Jalili IK. Cone-rod congenital amaurosis associated with congenital hypertrichosis: an autosomal recessive condition. J Med Genet 1989 26 : 504 510. (Pubitemid 19199892)
59. Toro J, Turner M, Gahl WA. Dermatologic manifestations of Hermansky-Pudlak syndrome in patients with and without a 16-base pair duplication in the HPS1 gene. Arch Dermatol 1999 135 : 774 780. (Pubitemid 29330799)
60. Verloes A, Massin M, Fransolet AC et al. Hypertrichosis, Fallot tetralogy, growth and developmental delay. Clin Dysmorphol 2004 13 : 247 250. (Pubitemid 40674500)
61. Pivnick EK, Wilroy RS, Martens PR et al. Hypertrichosis, pigmentary retinopathy, and facial anomalies: a new syndrome? Am J Med Genet 1996 62 : 386 390. (Pubitemid 26131118)
62. Osovsky M, Merlob P. Trichomegaly in two sisters with synophrys in the older sibling. Am J Med Genet A 2005 136 : 398. (Pubitemid 41076597)
63. Livingston S, Petersen D, Boks LL. Hypertrichosis occurring in association with dilantin therapy. J Pediatr 1955 47 : 351 352.
64. Sahai J, Conway B, Cameron D et al. Zidovudine-associated hypertrichosis and nail pigmentation in an HIV-infected patient. AIDS 1991 5 : 1395 1396.
65. Sampson JR, Tolmie JL, Cant JS. Oliver McFarlane syndrome: a 25-year follow-up. Am J Med Genet 1989 34 : 199 201. (Pubitemid 19257635)
66. Chang TS, McFarlane DC, Oliver G et al. Congenital trichomegaly, pigmentary degeneration of the retina and growth retardation (Oliver-McFarlane syndrome): 28-year follow-up of the first reported case. Can J Ophthalmol 1993 28 : 191 193. (Pubitemid 23250837)